Matches in SemOpenAlex for { <https://semopenalex.org/work/W4284994311> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4284994311 abstract "To date, no study evaluates the effect of atherosclerosis risk level on the efficacy of BPH drug therapies. Therefore, the present study aimed to assess the effect of atherosclerosis risk levels on the effectiveness of Tamsulosin and Tadalafil in LUTS treatment.The present study was a randomized clinical trial that assessed men with LUTS symptoms (at least six months). The inclusion criteria were being older than 50 years, international prostate symptom score (IPSS) ≥ 13, and maximum urinary flow rate (Qmax) between 4 and 15 ml/s. Framingham Risk Score was used to measure atherosclerosis risk. The patients were classified into four groups, including group 1: Patients with low risk and treated with Tamsulosin (0.4 mg/day), group 2: Patients with low risk and treated with Tadalafil (5 mg/day), group 3: Patients with high risk and treated with Tamsulosin (0.4 mg/day), group 4: Patients with high risk and treated with Tadalafil (5 mg/day).The study included 44 and 38 patients receiving Tamsulosin and Tadalafil, respectively. The means (SD) of the baseline age for the Tamsulosin and Tadalafil groups were equal to 60.6 (6.8) and 58.8 (6.7), respectively (p-value = 0.213). The models revealed no impact of the atherosclerosis risk level on the drugs' effects (p-values = 0.378, 0.975, 0.743 for IPSS, QMAX, and VOID, respectively).The present study's findings could not show the impact of atherosclerosis risk levels on the efficiency of Tamsolusin and Tadalafil in men with LUTS." @default.
- W4284994311 created "2022-07-11" @default.
- W4284994311 creator A5010716132 @default.
- W4284994311 creator A5014762258 @default.
- W4284994311 creator A5036079577 @default.
- W4284994311 creator A5054276792 @default.
- W4284994311 creator A5055915413 @default.
- W4284994311 date "2022-08-01" @default.
- W4284994311 modified "2023-10-18" @default.
- W4284994311 title "Comparison of Tamsulosin and Tadalafil effects in LUTS treatment considering patients’ atherosclerosis risk level" @default.
- W4284994311 cites W1575778540 @default.
- W4284994311 cites W1906097745 @default.
- W4284994311 cites W1967807453 @default.
- W4284994311 cites W1979612532 @default.
- W4284994311 cites W2006615433 @default.
- W4284994311 cites W2015122735 @default.
- W4284994311 cites W2022912254 @default.
- W4284994311 cites W2038693293 @default.
- W4284994311 cites W2050093658 @default.
- W4284994311 cites W2051838969 @default.
- W4284994311 cites W2070170982 @default.
- W4284994311 cites W2074917601 @default.
- W4284994311 cites W2082982324 @default.
- W4284994311 cites W2086558436 @default.
- W4284994311 cites W2087575044 @default.
- W4284994311 cites W2095674834 @default.
- W4284994311 cites W2128170439 @default.
- W4284994311 cites W2981467331 @default.
- W4284994311 cites W3190109435 @default.
- W4284994311 cites W4206042557 @default.
- W4284994311 cites W4211144482 @default.
- W4284994311 doi "https://doi.org/10.1016/j.amsu.2022.104137" @default.
- W4284994311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35846856" @default.
- W4284994311 hasPublicationYear "2022" @default.
- W4284994311 type Work @default.
- W4284994311 citedByCount "0" @default.
- W4284994311 crossrefType "journal-article" @default.
- W4284994311 hasAuthorship W4284994311A5010716132 @default.
- W4284994311 hasAuthorship W4284994311A5014762258 @default.
- W4284994311 hasAuthorship W4284994311A5036079577 @default.
- W4284994311 hasAuthorship W4284994311A5054276792 @default.
- W4284994311 hasAuthorship W4284994311A5055915413 @default.
- W4284994311 hasBestOaLocation W42849943111 @default.
- W4284994311 hasConcept C121608353 @default.
- W4284994311 hasConcept C126322002 @default.
- W4284994311 hasConcept C126894567 @default.
- W4284994311 hasConcept C168563851 @default.
- W4284994311 hasConcept C2776235491 @default.
- W4284994311 hasConcept C2776547966 @default.
- W4284994311 hasConcept C2777562237 @default.
- W4284994311 hasConcept C2779478474 @default.
- W4284994311 hasConcept C2779929075 @default.
- W4284994311 hasConcept C2780542891 @default.
- W4284994311 hasConcept C2780816001 @default.
- W4284994311 hasConcept C71924100 @default.
- W4284994311 hasConceptScore W4284994311C121608353 @default.
- W4284994311 hasConceptScore W4284994311C126322002 @default.
- W4284994311 hasConceptScore W4284994311C126894567 @default.
- W4284994311 hasConceptScore W4284994311C168563851 @default.
- W4284994311 hasConceptScore W4284994311C2776235491 @default.
- W4284994311 hasConceptScore W4284994311C2776547966 @default.
- W4284994311 hasConceptScore W4284994311C2777562237 @default.
- W4284994311 hasConceptScore W4284994311C2779478474 @default.
- W4284994311 hasConceptScore W4284994311C2779929075 @default.
- W4284994311 hasConceptScore W4284994311C2780542891 @default.
- W4284994311 hasConceptScore W4284994311C2780816001 @default.
- W4284994311 hasConceptScore W4284994311C71924100 @default.
- W4284994311 hasLocation W42849943111 @default.
- W4284994311 hasLocation W42849943112 @default.
- W4284994311 hasLocation W42849943113 @default.
- W4284994311 hasOpenAccess W4284994311 @default.
- W4284994311 hasPrimaryLocation W42849943111 @default.
- W4284994311 hasRelatedWork W1554249994 @default.
- W4284994311 hasRelatedWork W1969673967 @default.
- W4284994311 hasRelatedWork W2123001825 @default.
- W4284994311 hasRelatedWork W2760224047 @default.
- W4284994311 hasRelatedWork W2956107686 @default.
- W4284994311 hasRelatedWork W2981467331 @default.
- W4284994311 hasRelatedWork W3017592941 @default.
- W4284994311 hasRelatedWork W3202737522 @default.
- W4284994311 hasRelatedWork W3209401362 @default.
- W4284994311 hasRelatedWork W4283640214 @default.
- W4284994311 hasVolume "80" @default.
- W4284994311 isParatext "false" @default.
- W4284994311 isRetracted "false" @default.
- W4284994311 workType "article" @default.